C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/454 (2006.01) A61K 31/496 (2006.01) A61K 31/501 (2006.01) A61K 31/5377 (2006.01) A61P 11/06 (2006.01) C07D 231/38 (2006.01) C07D 237/20 (2006.01) C07D 401/04 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2687931
The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonarydiseases like asthma and COPD.
L'invention concerne de nouveaux antagonistes de CCR2 (récepteur 2 des chimiokines CC) et leur utilisation pour produire des médicaments destinés à traiter des états pathologiques et des maladies, notamment des maladies pulmonaires telles que l'asthme et la bronchopneumopathie chronique obstructive.
Ebel Heiner
Hobbie Silke
Peters Stefan
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Ccr2 receptor antagonists and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ccr2 receptor antagonists and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ccr2 receptor antagonists and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1595530